The secret’s out…… 👇 Absolutely honoured to have this award….. 🙏 National Institute for Health and Care Research Leeds CTRU Looking forward to working together with the other NIHR RPs 👍

Clinical academics are an endangered species Hope the Minister of State will take into account the conclusions and recommendations of the =House of Lords Science and Technology committee Please read the thread below and retweet 🙏🏽 NHS England National Institute for Health and Care Research Cancer Research UK

What fantastic news. Congratulations to you all. Love working with you Prof Deborah Stocken PhD and so excited for your future research and inspirational leadership

Really excited to be visiting the Myeloma UK garden tomorrow on behalf of Leeds CTRU and Myeloma UK CARP

I didn’t realise a garden could evoke an emotional response. But seeing the Myeloma UK A Life Worth Living garden today, Chris Beardshaw has created something spectacular. I’ve been inspired to think differently about the trials we develop. Myeloma UK thank you for inviting me.

Great opportunities with Cancer Research UK to develop leadership skills through coaching

Truly collaborative research. Results of the OPTIMUM MUKnine trial now out, providing evidence for myeloma patients with high risk disease. Martin Kaiser @JennerMatthew Myeloma UK Leeds CTRU

At Leeds CTRU, our people are our greatest asset. Our team of Clinical Trial Professionals work tirelessly to design and carry out clinical trials that improve patient outcomes. Together, we're making a real impact on people's lives 🙌 #LeedsCTRU #ClinicalResearch

This year’s #MCCR has been a blast. It’s always a privilege to work with such talented students, and to celebrate at the end of one of the most intense weeks of #clinicaltrial development. PDG3 you were amazing. Good luck with all your protocols.

Excellent opportunity to join this rapidly growing team and work with the brilliant Rebecca Walwyn Get in touch if you’re interested.

💥 12- vs 3-weekly IPI in #RCC (PRISM). Just out Journal of Clinical Oncology with extended FU Modified IPI (+nivo): • Significantly ⬇️ G3/4 toxicity ✅ • ORR 45%✅ • Comparable PFS/OS (32m FU)✅ ascopubs.org/doi/pdfdirect/… Tom Powles Lisa Pickering Prof Sarah R Brown 💙 @Oncology_Doctor LIMRLeeds